Christopher Stone
2015
In 2015, Christopher Stone earned a total compensation of $1.5M as Vice President, General Counsel and Secretary at PDL BioPharma, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $709,987 |
|---|---|
| Salary | $428,233 |
| Stock Awards | $327,990 |
| Other | $10,000 |
| Total | $1,476,210 |
Stone received $710K in non-equity incentive plan, accounting for 48% of the total pay in 2015.
Stone also received $428.2K in salary, $328K in stock awards and $10K in other compensation.
Rankings
In 2015, Christopher Stone's compensation ranked 6,068th out of 13,638 executives tracked by ExecPay. In other words, Stone earned more than 55.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,068 out of 13,638 | 56th |
Division Manufacturing | 2,269 out of 5,187 | 56th |
Major group Chemicals And Allied Products | 821 out of 1,857 | 56th |
Industry group Drugs | 657 out of 1,531 | 57th |
Industry Biological Products, Except Diagnostic Substances | 114 out of 260 | 56th |
Source: SEC filing on April 28, 2017.
Stone's colleagues
We found five more compensation records of executives who worked with Christopher Stone at PDL BioPharma in 2015.
2015
John McLaughlin
PDL BioPharma
Chief Executive Officer
2015
Peter Garcia
PDL BioPharma
Chief Financial Officer
2015
Danny Hart
PDL BioPharma
Vice President, Business Development
2015
David Montez
PDL BioPharma
Chief Accounting Officer
2015
Steffen Pietzke
PDL BioPharma